Literature DB >> 8007632

CSF beta-endorphin levels in pediatric neurologic disorders.

S Nagamitsu1.   

Abstract

To investigate pediatric brain impairment, beta-endorphin levels, one of the opioid peptides that modulate human high cortical functions, were measured in cerebrospinal fluid (CSF). The study included 19 patients with infantile autism, 3 patients with Rett syndrome, 6 patients with infantile spasms, 16 patients with aseptic meningitis, and 23 age-matched controls. In the control group, the CSF beta-endorphin concentrations were negatively correlated with increasing age. There was no correlation between body temperature and the levels, and no significant difference in the levels according to sex. In infantile autism, the CSF level was not significantly different from that in controls. In Rett syndrome, it was significantly higher, while in infantile spasms it was lower than in controls. In aseptic meningitis, the CSF beta-endorphin level was significantly higher than in controls. The alterations in CSF beta-endorphin levels may play a role in these neurologic disorders and/or in central nervous system (CNS) infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8007632     DOI: 10.2739/kurumemedj.40.233

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  7 in total

1.  CSF beta-endorphin levels in patients with infantile autism.

Authors:  S Nagamitsu; T Matsuishi; T Kisa; H Komori; M Miyazaki; T Hashimoto; Y Yamashita; E Ohtaki; H Kato
Journal:  J Autism Dev Disord       Date:  1997-04

Review 2.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

3.  Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques.

Authors:  Kim M Lee; Kevin B Chiu; Peter J Didier; Kate C Baker; Andrew G MacLean
Journal:  Brain Behav Immun       Date:  2015-07-17       Impact factor: 7.217

4.  Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters.

Authors:  Barbara Stanley; Leo Sher; Scott Wilson; Rolf Ekman; Yung-yu Huang; J John Mann
Journal:  J Affect Disord       Date:  2009-11-25       Impact factor: 4.839

5.  Cerebrospinal fluid and plasma β-endorphin levels in children with cerebral malaria.

Authors:  Oluwatosin Eunice Olorunmoteni; Oluwagbemiga Oyewole Adeodu; Saheed B A Oseni; Efere M Obuotor
Journal:  Brain Behav       Date:  2017-03-17       Impact factor: 2.708

Review 6.  The Current View on the Paradox of Pain in Autism Spectrum Disorders.

Authors:  Olena V Bogdanova; Volodymyr B Bogdanov; Adrien Pizano; Manuel Bouvard; Jean-Rene Cazalets; Nicholas Mellen; Anouck Amestoy
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

7.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.